Adding A New Drug To Your Practice

There is a new FDA approved drug on the market in the States. Xeomin recently received its stamp of approval to treat cervical dystonia and blepharospasm. After getting certified, doctors may use it off-label to treat fine lines, wrinkles, and crows feet, making Botox its biggest rival.

When adding a new drug to your practice, there should be a guideline to why you are adding it and how to position it? Do you currently need another botulinum toxin type A injectable? What percentage of your aesthetic business is brought in by injectables and which is most popular? Are you hearing a need from your client that your current options do not provide?

It may sound like a lot of philosophizing but all these questions can be answered seamlessly with a Profit Accelerator. This program will break down you current revenue to get a look at what your true driving force is and also be able to compare it with your marketing strategy to see where your dollars are being spent and if that is a beneficial route for you to continue to take.

Best of all, the results are measurable.

If you have not yet done a Profit Accelerator with us and are interested. Call us and take 10 minutes with us to share your needs and clearly understand how we can help.

Toll Free:

1-877-711-2582

or

info@ABandT.com